USA flag logo/image

An Official Website of the United States Government

Search

Note: The awards database is continually being updated to reflect accurate data as agencies upload their award information

Narrow Search Filters:
State:North Carolina
Download to spreadsheetPrint
Displaying 51 – 75 of 2194 Awards
Company: Corvid Technologies, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: Corvid Technologies is excited to offer a unique solution for protecting tactical vehicles during high-speed external transport. The innovative design employs a fabric net structure rigged to the vehicle which significantly reduces the impeding air velocity on critical components. This approach… more
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Standard microfracture is a first-line, widely used and cost-effective surgical technique for repairing damaged articular cartilage, but, it is limited by decreased long-term efficacy and limited applicability in largerlesions. This leads to a burgeoning economic… more
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Controlling mechanical signal transduction to treat osteoarthritis Abstract The TRPV4 calcium (Ca++) permeable ion channel has been shown to be expressed and functional in chondrocytes, the cells responsible for the maintenance of cartilage in weight-bearing… more
Company: CYTEX THERAPEUTICS INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): The overall goal of this study is to develop a tissue-engineered total joint replacement from an engineered biomaterial scaffold combined with adult bone marrow-derived mesenchymal stem cells (MSCs) for regeneration ofthe entire femoral surface of the hip joint.… more
Company: GENOMEX Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): The goal of this Phase I effort is determine the feasibility of developing a unique antimicrobial catheter to reduce the instances of the most prevalent healthcare associated infection, Catheter-Associated Urinary TractInfection (CAUTI). This research and… more
Company: GRASSROOTS BIOTECHNOLOGY, INC. Agency/Program/Year/Phase: USDA / SBIR / 2013 / 1
Abstract: Sorghum is a major crop for food, feed and industrial processes in the US and on the global market. It is a particularly relevant crop under the current pressures of climate change and food security because it is adapted to cultivation under low water and nutrient conditions. However, compared to… more
Company: HEART IMAGING TECHNOLOGIES, LLC Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Medical drugs and devices are regulated by the U.S. Food and Drug Administration (FDA) based on data from multicenter clinical trials. In 2010, U.S. spending on clinical trials was approximately 25 billion. Over the past decade the efficiency of clinical trials… more
Company: International Association of Virtual Org Agency/Program/Year/Phase: NASA / SBIR / 2013 / 1
Abstract: DyMA-FM (Dynamic Multivariate Assessment for Fault Management) is a software architecture for real-time fault management. Designed to run in a distributed environment, DyMA-FM enables model-based reasoning and predictive modeling for FM applications. With the appropriate hardware, DyMA-FM can… more
Company: G1 THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Acute kidney injury (AKI) is common, expensive, and highly morbid. There are currently no therapies for AKI, and prevention and treatment represents a 6.3 billion market opportunity annually in the U.S. Moreover, patients are developing AKI more frequently and… more
Company: G1 THERAPEUTICS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Myelosuppression continues to represent the major dose-limiting toxicity of cancer chemotherapy, resulting in considerable morbidity and mortality along with frequent reductions in chemotherapy dose intensity, which maycompromise disease control and survival.… more
Company: AGILE SCIENCES, INC. Agency/Program/Year/Phase: HHS / STTR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Patients with infective endocarditis (IE) have a poor prognosis with one third of the patients succumbing to the infection within the first year. Treatments for endocarditis involve antibiotic therapy and/or surgery that cost upwards of 100,000 per patient;… more
Company: INNOVATION RESEARCH AND TRAINING, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Training mentored youth and their caregivers to work together successfully with their mentor and mentoring program is critically important for achieving a safe, high-quality, sustained mentoring relationship, and for obtaining positive youth outcomes. Training… more
Company: INNOVATION RESEARCH AND TRAINING, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: Adolescents with Fetal Alcohol Spectrum Disorder (FASD) are at risk for substance use and abuse. Given the dearth of Interventions designed specifically for adolescents with FASD, there exists a need for evidence-based preventive intervention programs forthis population. Thus, the goal of the… more
Company: INTEGRATED LABORATORY SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: PROJECT SUMARY/ABSTRACT This proposed project is in response to the need for more extensive toxicological evaluation of environmental chemicals and for predictive models to assess associated risks of chemical exposure to humans. There is also need for innovative methods for evaluating the effects of… more
Company: INTEGRATED LABORATORY SYSTEMS, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: Not Available
Company: Kyma Technologies, Inc. Agency/Program/Year/Phase: DOE / SBIR / 2013 / 1
Abstract: Although several critical energy saving technologies under development today require Gallium Nitride (GaN) based semiconductor devices, a source of high quality and inexpensive GaN wafers does not yet exist. This lack of GaN wafers adds complexity to GaN device production and makes development of… more
Company: Kyma Technologies, Inc. Agency/Program/Year/Phase: DOE / SBIR / 2013 / 1
Abstract: Gallium Nitrides (GaN) device market size is second only to silicon and is projected to be $50-100 billion in size as markets mature for GaN power devices, solid state lighting, and hundreds of other new applications. Even with this remarkable forecast, GaN epitaxy is still produced primarily on… more
Company: Kyma Technologies, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: Gallium Nitride (GaN) crystals have recently garnered attention as a candidate for use as a Quasi-Phase Matching (QPM) material for frequency conversion applications such as second harmonic generation (SHG) and optical parametric oscillation (OPO), due to its wide bandgap (3.4eV), high thermal… more
Company: Mercury Science Inc. Agency/Program/Year/Phase: DOC / SBIR / 2013 / 2
Abstract: In Phase I, a novel porous electrode was designed to demonstrate a rapid, simple assay for the detection of domoic acid in marine samples. During Phase II, methods to manufacture porous electrodes will be improved to enable high volume production of low-cost biosensors that can be connected to a… more
Company: NanoTechLabs Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: Through this effort, NanoTechLabs Inc. will improve the efficiency and lower the mass of the cryogenic heat exchanger used in American Superconductor's High Temperature Superconducting Degaussing system. NanoTechLabs will achieve these goals by producing a Carbon Nanotube metal matrix composite… more
Company: NanoTechLabs Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: ABSTRACT: Through the Phase II program, NTL will finalize the materials development and demonstrate the ability of a TIM material based on carbon nanotube vertical arrays to meet general requirements for space applications. In addition we will define and initiate tests required for a specific Air… more
Company: PARION SCIENCES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 1
Abstract: DESCRIPTION (provided by applicant): Mucus transport is the fundamental defense of the airways against inhaled particulates/infectious agents. Abnormalities in the mucus transport system characterize a complex of muco-obstructive airway diseases, such as cystic fibrosis (CF) and chronic bronchitis… more
Company: PARION SCIENCES, INC. Agency/Program/Year/Phase: HHS / SBIR / 2013 / 2
Abstract: DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is an autosomal lethal disease characterized that affects ~30,000 individuals in the US. CF lung disease, the major cause of mortality in CF, is caused by dehydration of airway secretions that leads to mucous adhesion, infection and airways… more
Company: Signal Innovations Group, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 1
Abstract: Signal Innovations Group proposes a hierarchical Bayesian approach for non-linear dimensionality reduction that addresses three key challenges: learning a reversible mapping from a high-dimensional observed space to a low-dimensional embedded space, learning the dimension of the embedded space, and… more
Company: Signal Innovations Group, Inc. Agency/Program/Year/Phase: DOD / SBIR / 2013 / 2
Abstract: The detection and tracking of dismounts and the identification of threatening dismounts are critical challenges for ensuring mission success and troop safety when conducting tactical vehicle operations in hostile environments. Vehicle operators must focus on multiple tasks simultaneously: … more
Displaying 51 – 75 of 2194 Awards
Narrow Your Search
By Agency
By Year
By Phase
By Program
By State
By Company Ownership
By Company
HELP FOR NARROW YOUR SEARCH

Search Options

There are several categories such as “By Agency”, “By Year”, “By State” etc. Select a checkbox within a category to refine your search results.

Each of your selections is listed in the “Narrow Search Filters” bar. You can uncheck these selections to remove them.


Search for Either Criteria

When you select multiple values within a category, the results will include values that match either of the selections. For example, selecting “2005” and “2007” in the “By Year” category will display results that include either 2005 OR 2007 in the results.


Narrowing the Search Results

You can refine your search results across categories. To narrow down your results, select multiple values across different categories. The results will only include values that match the selections across the categories. For example, selecting “2005” in the “By Year” category and “NASA” in the “By Agency” category will only display the results that contain both “2005” AND “NASA” in the results.